A capital ISRG 2 years ago told me about TITXF. At that time he was concerned about future competition from TITXF. Currently I know many of the reps are concerned about their domination of the market being impacted by SPORT. I know little about stocks but I've been a physician for 15 years and as a gynecologist I use robotics weekly. Currently nothing besides SPORT will be ready to compete with TITXF. Those videos from SAGES show a great product from my standpoint. As hospital admins are always looking for the "cheaper" product for their OR, SPORT will be the easy choice. I don't need to see the Surgibot in person at SAGES to tell you that it will not be in many ORs in the future. It's clear from watching their online videos. As a surgeon robotic surgery is where laparoscopic (most) surgery is going. There is now a clear competitor to TITXF. I'm not worried about the FDA approval. I am a little concerned about ISRG trying to block it's going to market because of some patent violation. Any attorneys out there that think this might be an issue?
News 
Market Data 
Discover 
AI
